Ventimiglia Jeffrey, Kalali Amir H
Mr. Ventimiglia is Analyst, Strategy and Solutions, Global Customer Management, Quintiles, Inc., Durham, North Carolina.
Psychiatry (Edgmont). 2010 Jun;7(6):9-11.
In this article, we explore the accelerated penetration of generic antidepressants in the United States market following the availability of generic citalopram and sertraline. Analysis suggests that overall, generic penetration into the antidepressant market has grown from approximately 41 percent in January 2004 to over 73 percent in January 2010. Similar trends are uncovered when branded and generic prescriptions are analyzed by specialty.
在本文中，我们探讨了在西酞普兰和舍曲林仿制药上市后，仿制药在美国抗抑郁药市场的加速渗透情况。分析表明，总体而言，仿制药在抗抑郁药市场的渗透率已从2004年1月的约41%增长至2010年1月的逾73%。按专科分析品牌药和仿制药处方时，也发现了类似趋势。
